Table 3 Biochemical parameters for dual therapies—DPP4I study, Anuradhapura 2017
Investigation | OOH group (n = 123) | DPP4I group (n = 07) | Estimated difference of means (95% CI) | p value* | ||
|---|---|---|---|---|---|---|
Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | |||
HbA1C (%) | 8.4 (7–10) | 8.8 (1.9) | 7.5 (7–8) | 7.7 (1.2) | − 1.1 (−2.5 to 0.3) | 0.110 |
Pancreatic amylase (U/L) | 36 (27–48) | 44.3 (57.6) | 58 (32–97) | 60.1 (33.1) | 15.8 (−27.8 to 59.4) | 0.095 |
Serum lipase (U/L) | 45 (35–60) | 48.7 (18.8) | 60 (52–148) | 91.6 (48.1) | 42.9 (26.7 to 59.1) | 0.007 |
AST (U/L) | 23 (17–29) | 26.2 (18.5) | 23 (22–28) | 24.1 (7.2) | − 2.1 (−16.0 to 11.8) | 0.912 |
ALT (U/L) | 22 (15–33) | 26.1 (15.5) | 24 (18–29) | 23.4 (7.6) | −2.7 (−14.4 to 9.0) | 0.992 |